In one paragraphArticle in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Bassel J AbdallaDepartment of Microbiology, Genetics & Immunology, Michigan State University, East Lansing, Michigan 48824, United States.
Matthew B GilettoDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States.
Nazli Goksel CarpaDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, United States.ORCID 0009-0002-0924-1890 Angela K WilsonDepartment of Chemistry, Michigan State University, East Lansing, Michigan 48824, United States.ORCID 0000-0001-9500-1628 Edmund EllsworthDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, United States.
Robert B AbramovitchDepartment of Microbiology, Genetics & Immunology, Michigan State University, East Lansing, Michigan 48824, United States.ORCID 0000-0002-4119-4169 Funding
Chemical biology studies of MmpL3 inhibition and resistance in mycobacteriaR01AI173285 · NIAID · MICHIGAN STATE UNIVERSITY · PI Robert B Abramovitch, Edmund L Ellsworth · 2023 to 2026
$2.9MIntegrative Pharmacological Sciences Training Program (IPSTP)T32GM142521 · NIGMS · MICHIGAN STATE UNIVERSITY · PI ANNE M. DORRANCE, Gina Marie Leinninger · 2021 to 2026
$2.4MDevelopment of new M. tuberculosis MmpL3 inhibitorsR21AI148909 · NIAID · MICHIGAN STATE UNIVERSITY · PI ABRAMOVITCH, ROBERT B · 2020 to 2021
$423kNIAID NIH HHS R01 AI173285NIAID NIH HHS R21 AI148909NIGMS NIH HHS T32 GM142521
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsMycobacterium abscessusDrug Resistance, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsMembrane Transport Proteins
Identifiers
PMID41529103
PMCPMC12930390
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390